An anonymous director reports
SUPREME PHARMACEUTICALS ANNOUNCES DEBT SETTLEMENT FOR SHARES
Supreme Pharmaceuticals Inc. has settled outstanding debts by the issuance of 500,000 shares at a deemed price of 33.75 cents per share. These shares shall be subject to a four-month trading restriction.
© 2024 Canjex Publishing Ltd. All rights reserved.